COMPASS Pathways (NASDAQ:CMPS – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect COMPASS Pathways to post earnings of ...

COMPASS Pathways (NASDAQ:CMPS – Free Report) had its price target reduced by HC Wainwright from $60.00 to $45.00 in a report ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, a ...

After hours: February 14 at 7:42:13 p.m. EST ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.

The Home Office has announced the Safer Streets fund, launched in 2020 with five different rounds, will not continue into the ...